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We have developed biodegradable fibrin-derived
microbeads as potent cell carriers. The fibrin-derived
microbeads, 50–200 mm in diameter, were tested for
their attachment to a wide range of cell types. Fibrin-
derived microbeads were shown to be greatly
haptotactic to cells (such as endothelial cells, smooth
muscle cells and fibroblasts), which respond to
fibrinogen in contrast to keratinocytes and different cell
lines derived from leukocytic lineage. The cells on
fibrin-derived microbeads could be maintained for
more than 10 d and achieved a high density. 31P-nuclear
magnetic resonance was employed to monitor
phosphate metabolism in cells, with densities on the
order of 100 million cells per g of fibrin-derived
microbeads. The 31P-nuclear magnetic resonance
adenosine triphosphate and phosphocreatine signals,
equivalent to the signal obtained with perfused normal
skin, indicated that metabolism of cells on fibrin-
derived microbeads was responsive to oxygenation and
nutrients. Light, fluorescent, and confocal laser
Fibrinogen and thrombin each exert proliferative andadhesive effects on cultured fibroblasts and other cells.Specifically, fibrin(ogen) and its various lytic fragments(i.e., FPA, FPB, fragments D and E) were shown to bechemotactic to macrophages, human fibroblasts, and
endothelial cells (Lorenzet et al, 1992; Brown et al, 1993; Gray et al,
1993). Thrombin also has been shown to exert proliferative and
adhesive effects on cultured cells (Shuman, 1986; Daniel et al, 1986;
Bar-Shavit et al, 1990; Dawes et al, 1993). We showed previously that
coating inert Sepharosebeads (SB)with eitherfibrinogenor thrombin
rendered them adhesive to a wide range of cell types. We used
protein-coated SB to detect and grade the affinity of cells for the
tested proteins and to screen normal and transformed cells for their
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microscopy revealed that the porous fibrin-derived
microbeads accommodate up to 200–300 cells due to
their high surface area which minimized contact
inhibition. Cells could degrade the fibrin-derived
microbeads and be transferred to seed culture flasks
without trypsinization. In a pig skin wound healing
model, fibrin-derived microbeads F fibroblasts were
transplanted into full thickness punch wounds. This
procedure was compared with other treatment
modalities, such as the addition of human platelet-
derived growth factor BB or fibrin-derived microbeads
alone. By the third day after wounding, only the
wounds in which fibroblasts on fibrin-derived
microbeads were added showed significant formation
of granulation tissue. Based on the above, we project
many uses of our novel fibrin-derived microbead
technology for cell culturing, wound healing and tissue
engineering. Key words: 31P-nuclear magnetic resonance/
fibrin(ogen)/haptotaxis/microcarriers/proliferation. J Invest
Dermatol 112:866–872, 1999
haptotactic responses to fibrin(ogen) and thrombin (Gorodetsky
et al, 1998).
Microcarriers beads made of some plastic polymers or glass
provide cells with a surface area on the order of 104 cm2 per liter
for cell attachment, which is one order of magnitude larger than
the area available with stack plates or multitray cell culture
facilities (Griffith and Looby, 1997). From the point of view
of transplantation biology, the major disadvantage of such cell
microcarriers is that most of them are not biodegradable or
immunogenic. Others have prepared microparticles from plasma
proteins, such as albumin or fibrinogen, generally using glutar-
aldehyde to cross-link the proteins. Glutaraldehyde, however, is
not appropriate for preparing cell culture matrices as such cross-
linking slows down degradation of the matrix or blocks the protein
epitopes, which may attract cells. Consequently, glutaraldehyde
cross-linked microcarriers have been used mainly for drug release
or imaging (Evans, 1972; Lee et al, 1981; Royer, 1982; Yapel,
1985; Miyazaki et al, 1986a, b, c; Arshady, 1990; Gref et al, 1994).
Based on our experience with the attraction of many normal
cell types to fibrin(ogen) with minimal effect on their proliferation
(Gorodetsky et al, 1998), we fabricated small particles (microbeads)
of fibrin (FMB) to be used for high cell density culture. The
fibrin(ogen), which is the main component of these beads, is not
immunogenic and can be biodegraded within a few days. This
paper describes the fabrication of FMB, the attachment and growth
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Table I. Biochemical composition of fibrinogen source
Pooled cryo Pure fibrinogena
Protein (mg per ml) 72 6 10 41 6 5
Fibrinogen (mg per ml) 13 6 5 40 6 5
Fibronectin (mg per ml) 3 6 1 1 6 1
IgG (mg per ml) 13 6 2 trace
XIII (U per ml) 5 6 1 20 6 10
aPurified by fractionation.
of cultured cells on FMB, and their transplantation into an animal
skin wound to accelerate healing.
MATERIALS AND METHODS
Fibrinogen Fibrinogen, prepared by fractionation of pooled plasma, has
been virus inactivated by the solvent detergent (S/D) process and is a
component of clinical grade fibrin sealant (Marx et al, 1996; Sanders
et al, 1996). Cryoprecipitate was obtained from frozen and thawed pooled
S/D plasma. The biochemical components of the fibrinogen sources are
presented in Table I.
Thrombin Human thrombin (stock 200 U per ml) was prepared as
described (Zou et al, 1997); its activity was determined by clot time assays
calibrated against an international standard.
FMB preparation A typical preparation of FMB was carried out by
heating 400 ml corn oil 1 isooctane (1:1) to 75°C with mechanical stirring.
A solution of fibrinogen (25 ml; 40 mg per ml) or cryoprecipitate, diluted
1:4 in Tris/saline buffer (pH 7.4) with 5 mM Ca12, was mixed with
thrombin to 5 U per ml (final concentration). The protein mixture was
added to the heated oil at a rate so that the protein solution had not yet
coagulated, and where the stirring dispersed the aqueous phase into oil-
suspended droplets. Mixing and heating continued at µ75°C for 6–8 h.
The crude FMB was filtered off, washed with hexane, 95% ethanol, and
air dried.
Solubility tests and sodium dodecyl sulfate–polyacrylamide gel
electrophoresis (SDS–PAGE) The FMB were tested for solubility in
Tris/saline or in 4 M urea. Neither the Tris buffer nor the 4 M urea
dissolved FMB for up to 1 wk at room temperature. As FMB are not
soluble, they were partially digested to obtain material for analysis. One
hundred micrograms FMB were suspended in 1 ml 0.1 M NaOH, the
supernatant samples were removed after 1 or 2 d and subjected to reduced
4–12% gradient SDS–PAGE (Nova, Encino, CA), using fibrinogen or
normally clotted fibrin as controls.
Cell cultures The following cell types were used in this study:
cultured normal human skin fibroblasts (HF) were isolated from skin
biopsies of young human subjects and normal murine fibroblasts from the
skin of 2–3 d old neonate C3H mice, as previously described (Gorodetsky
et al, 1998), both cell types were grown for at least 12 passages. Syngeneic
porcine fibroblast for wound healing experiments were grown up to three
passages and isolated as previously described (Clark et al, 1996). Porcine
smooth muscle cells were separated from thoracic aortas of young animals
were grown up to 10 passages; normal human keratinocytes and normal
bovine aortic endothelial cells from young animals were isolated and grown
as previously described (Gorodetsky et al, 1998). Other cell lines tested
were murine fibroblast line (3T3), murine leukemic cell line (p-388), human
ovarian carcinoma line (OV-1063), murine mammary adenocarcinoma cells
(EMT-6), and murine macrophage-like cell line (J774.2) all grown and
maintained as previously described (Gorodetsky et al, 1998).
Culture medium components were purchased from Biological Industries
(Beit-HaEmek, Israel) and fetal calf serum was supplied by GIBCO (Grand
Island, New York, NY). The cell cultures were maintained at 37°C in a
water-jacketed CO2 incubator, and harvested by trypsin/versen solution
with one to two passages per week in a split ratio of 1:10 for fast
proliferating transformed cells and 1:4 for normal cell types.
FMB attachment assay The attachment of FMB to cells was compared
with the cell response to fibrinogen-coated SB as recently described
(Gorodetsky et al, 1998). Essentially, FMB were added to a growing
culture and counted periodically by visual inspection with inverted phase
microscope. Initially, all the beads freely rolled over the near confluent
culture. At different time intervals, the fraction of beads anchored to the
cells were counted (typically 300 beads but not less than 200 beads/plate)
and the ratio of beads bound to the cells, relative to the total number of
beads, was calculated. Experiments were carried out in triplicate.
Loading cells on FMB Prior to use, FMB were suspended in sterile
alcohol for 1 h, rinsed in sterile saline, incubated in 0.1% azide overnight
at 37°C and rinsed extensively with sterile saline. The cells to be loaded
on the FMB were grown in large plastic tissue culture dishes in their
normal growth conditions. Prior to reaching confluence, the cells were
trypsinized, collected, and added to a number of 50 ml polycarbonate
tubes, each with up to 1–10 million cells per 300 mg of beads suspended
in about 6 ml of medium. The tubes were covered by perforated aluminum
foil and loaded on a stand that slowly rotated the tubes at about 10 cycles
per minute at an angle of 30°, so that the medium did not reach the
perforated stoppers. The stand was placed in the CO2 tissue culture
incubator. A day after mixing the cells with FMB, the unattached cells
were separated by brief vortexing, the tubes were kept still for 60–90 s to
allow the FMB loaded with cells to sediment. The supernatant medium
containing unattached cells as well as small fragments of FMB was removed
and fresh medium added. The cells could continue growing on the FMB
in the rotating device for more than 4 d.
For growth rate experiments with pig kidney epithelial cells, the serum
content was set at 1%, 2%, 5%, and 10%. At regular intervals, a 100 µl
sample was vortexed 3 s to disperse clumps, the particulate FMB allowed
to settle (1 min) and the cell number was determined.
Assay for cell number Cell density was evaluated by the CellTitre
96Aqeous colorimetric assay (MTS assay) as previously described (Gorodet-
sky et al, 1998). Typically, the samples of 200 µl of suspended FMB 1
cells were placed in 24 well flat bottom plates (in triplicate) and 200 µl of
freshly prepared mixture of MTS/PMS (CellTitre 96 AQueous Assay by
Promega, Madison, WI) were added to each well; the plate was placed on
a mechanical plate incubator shaker. After 2–6 h of incubation at 37°C,
0.1 ml of the supernatant was transferred to a 96 well plate. The optical
density of the dye was read in a computerized automatic microwell plate
spectrophotometer (Anthos HT-II, Salzburg, Austria) at 490 nm. The time
points in which the optical density readings were within the optimal range,
were chosen for the assay of cell density. For all cell types tested, the
optical density readings of the MTS correlated well (r . 0.97–0.99) with
the number of seeded cells.
Light, fluorescent and confocal laser microscopy Light and fluores-
cent microscopy was carried out using an Olympus Fluorescent Microscopy
system at magnification range 3200–3860. Micrographs were taken by
single or double (fluorescence and light) exposures.
A computerized confocal laser microscope (Zeiss Confocal Axiomate
LSM410), using 363 objective with double excitation at 410 and 543 nm,
was used to visualize the endogenous fluorescence of the FMB and the
cell nuclei stained with propidium iodide (PI). The FMB loaded with cells
were fixed in 0.5% buffered glutaraldehyde. Before examination, 50 µg
per ml PI was added in darkness for at least 20 min; the FMB were then
placed on a microscope slide with phosphate-buffered saline/glycerol 80%
and 2% DABCO, then scanned by the confocal microscope. The visual
images (phase and differential interference contrast according to Nomarski)
and the fluorescent slice scans were processed for overlap slice summation
or 3D presentation.
Electron microscopy Samples of cells on FMB were fixed for scanning
electron microscopy (SEM) by 2.5% glutaraldehyde, prepared by critical
point drying, coated with osmium tetroxide, sputter coated with Au/Pd
and examined with a Hitachi S-530 Scanning Microscope.
31P-nuclear magnetic resonance (NMR) of cells loaded on
FMB Fibroblasts, endothelial and EMT-6 cells were loaded on FMB (at
about 100 million cells per g packed beads). About 1 g of FMB with cells
were placed in a sterile NMR tube and perfused with the culture medium
and a gas mixture of 95% O2/5% CO2 for up to 24 h. As a control, fresh
mouse skin was cut into 2 mm wide strips, placed in the NMR tube and
perfused with the medium. The 162 MHz 31P-NMR spectra of the
perfused samples were recorded on-line using Bruker AMX-400WB
spectrometer (Sharoni et al, 1996). Spectra were acquired using scans
accumulated with 1 s delay between the 45° pulses, spectral width of
8.5 kHz and 8000 data points. The intensity changes of the NMR
resonances corresponding to inorganic phosphate (Pi), phosphocreatine
(PCr) and the β-resonance of adenosine triphosphate (ATP) were recorded.
Pig skin wound healing model Full thickness excisional wounds were
made by an 8 mm circular punch into the paravertebral skin of Yorkshire
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pigs as previously described (Welch et al, 1990; Clark et al, 1996; McClain
et al, 1996). To each wound space, 150 µl of 3 mg per ml fibrinogen
mixed with 2 U per ml human α-thrombin were added. In some wounds,
prior to the addition of the fibrin, 0.6–1.0 million of cultured human
fibroblasts in suspension or on FMB were added to the bottom of the
wound. As the wounds were harvested at day 3 after the addition of
fibroblasts, rejection of xeno-implanted cells was not observed. In some
wounds, human platelet-derived growth factor BB (PDGF-BB), a known
chemotactic agent (Koyama et al, 1994) kindly provided by Ortho-McNeil
(Princeton, NJ), was added to the fibrinogen/thrombin solution prior to
applying it to the wound. Still other wounds received all additives. Wound
sites were dressed with Tegaderm, a polyurethane occlusive dressing, and
harvested after 3 d. Each formulation was tested in triplicate (n 5 3).
Specimens from all wound sites were dissected vertically. One half was
fixed with formalin, paraffin embedded, sectioned at 5 µm and stained with
Masson trichrome to delineate morphologic alterations. The sections, which
approximated the plane that vertically transected the center of each wound,
were numerically coded and visually evaluated on a Nikon BHK-2
microscope by an observer who had not participated in the animal
experiments.
Statistics The results of cell attachment and proliferation are represented
as an average of two to four experiments. Mean values and standard errors
were calculated for each point from the pooled normalized data. Statistical
analysis of the significance of paired data was performed using the Student’s
t-test, assuming equal and unequal variance as dictated by the ANOVA test.
RESULTS
FMB characterization FMB fabrication generated about 60%
weight/weight yield of FMB from starting protein solutions. The
FMB were not soluble in either physiologic buffers or 4 M urea
for up to 1 wk at room temperature. This suggests significant cross-
linking of the proteins. In order to evaluate this directly, 100 µg
FMB were digested in 1 ml 0.1 M NaOH for 1 or 2 d and the
supernatant was analyzed by reduced SDS–PAGE and compared
with control fibrinogen and fibrin. Densitometry of the gels showed
that FMB contained many more cross-links than observed with
normally clotted fibrin, which usually show only γ–γ dimers, loss
of α and γ bands as well as α-α multimers (Fig 1).
Attachment of FMB to cells We monitored the propensity of
FMB as well as Sb-Fib to be attached to the cells. Thus, either
FMB or Sb-Fib were applied on to a near confluent human
fibroblast culture and the proportion of beads that became attached
to the cells were counted daily by phase contrast microscopy, as
previously described (Gorodetsky et al, 1998). Control protein
noncoated SB did not interact with the cells and floated freely in
the culture medium even after prolonged incubation for up to a
week (0% attachment). By contrast, by day 3, we observed that
the attachment kinetics of FMB to fibroblasts were similar to the
response elicited by SB-Fib (Table II).
The attachment of FMB to other normal and transformed cells
corresponded to the cell interactions with SB-Fib (Fig 2, Table II).
Cells such as keratinocytes, OV-1063, and J-774.2 did not
significantly attach any of the beads; whereas transformed or
normal human and murine fibroblasts as well as smooth muscle,
endothelial, and EMT-6 cells attached the FMB with equal or
greater degree than SB-Fib.
Rate of attachment of cells to FMB The kinetics of haptotactic
response of fibroblasts, endothelial and smooth muscle cells to FMB
(Fig 2A) was similar to their responses to Sb-Fib (Gorodetsky et al,
1998). By day 3, most FMB were anchored to the cell layers.
Growth kinetics on FMB In the interest of observing the rate
of cell proliferation on FMB, we monitored the growth of pig
kidney epithelial cells on FMB maintained in culture medium
containing from 1% to 10% serum (Fig 2B) with twice weekly
medium replacement. The results indicate that with 10% serum, a
7-fold increase in cell number could be achieved after 1 wk. By
day 15, at the optimal conditions the cells had proliferated more
that 303. Cell proliferation at lower serum concentrations as
recorded from day 10 onward was significantly lower (p , 0.01).
Figure 1. Densitometric tracings of reduced SDS–PAGE of:
fibrinogen; fibrin; and partial NaOH digest of fibrin microbeads.
It is apparent that the degree of fibrin cross-linking in FMB is much more
extensive than in the fibrin clot as evident by the presence of high and
low molecular weight fragments.
Table II. Cell attachment to SB-fibrinogen and FMB (%)a
Cells SB-Fibrinogen FMB
Human fibroblasts 70 .95
Murine fibroblasts 82 .95
Human keratinocytes 0 0
Porcine smooth muscle cells 75 .95
Bovine endothelial cellsb .95 .95
Pig kidney epithelial cells ND .95
3T3/NIH fibroblasts 90 .95
OV-1063 human ovarian carcinoma cells 0 10
EMT-6 murine mammary carcinoma cells 62 94
4T1 murine mammary carcinoma cells .90 .90
Human melanoma cells .90 .90
J-774.2 Murine macrophage-like cells 0 0
aSB with covalently bound fibrinogen (SB-Fib) or FMB were placed on nearly
confluent culture and the percentage of beads attached to the cells at day 3 was
counted. Naked SB did not attach (O percentage).
bDifferent batches of endothelial cells show a wide range of responses.
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Figure 2. Responses of cells to FMB. (A) Rates of FMB attachment
(haptotaxis) to fibroblasts, smooth muscle, and endothelial cells. The
percentage of the FMB that were attached to the cultured cells at different
time points was monitored by light microscopy. Standard errors of the
measurements were in the range of 3%–8%. Endothelial cells and mouse
fibroblasts attached to FMB much faster than fibroblasts and smooth muscle
cells as seen following 24 and 48 h of incubation (p , 0.05). But similar
degree of attachment was recorded at day 4 where binding of all the beads
by the different cell types was reached. (B) Rates of proliferation of pig
kidney epithelial cells. About 1 million cells were loaded on FMB and
maintained at different media conditions. Cell number on FMB was
evaluated by the MTS assay. By day 7 only the growth of cells in 1%
serum was significantly different from the cell growth with other serum
concentrations The difference in the growth of cells in different serum
concentrations turned out to be fully significant (p , 0.01) from day 10
in the culture onwards.
The attachment and growth of cells on FMB was visualized by
various microscopic techniques. By SEM, we could observe many
fibroblasts attached on to a single bead with intimate contact
between the cell membranes and the FMB in a manner where it
was difficult to observe a boundary between the cell membrane
and the surface of the microbead (Fig 3). Figure 4(a) shows a
confocal microscopy image of a high titer (100 million cells per g
FMB) of EMT-6 cells that were loaded on to FMB for 24 h. This
image represents a composite of 50 optical slices through the FMB
loaded with cells shown by their red-stained nuclei (about 8 µm
in diameter). The number of cells attached to an average FMB
(50–100 µm in diameter) ranged from 70 to 250 cells which
Figure 3. SEM of fibroblasts on FMB. The cell membranes appear to
merge with the surface of the FMB.
typically were distributed over the whole surface and penetrated
into invaginations in the FMB.
When HF were grown with smaller FMB (about 30 µm in
diameter) for 3 d and observed by fluorescent microscopy, the cell
visualized by their red-stained nuclei covered the FMB surfaces
and appeared to aggregate the FMB into a tissue-like matrix with
high cell density (Fig 4b).
Cell transfer with FMB The downloading of HF from FMB
that was embedded in a droplet of fibrin (20 mg per ml) on a tissue
culture plate was studied. After 3 d of incubation, the red-stained
nuclei of the cells could be seen by combined fluorescent and light
microscopy to expand away from the densely populated FMB into
the intermediate soft fibrin gel, leaving translucent vacuoles of
digested gel (Fig 4c, around lower bead—B2). Some of the
migrating cells reached the area beyond the fibrin and settled on
to the less populated plastic surface. This phenomenon was also
visualized with confocal fluorescent microscopy, where the PI-
stained nuclei revealed an expanding front of HF leaving the high
cell density area on the FMB, while digesting the FMB and the
surrounding fibrin gel (Fig 4d).
31P-NMR Fibroblast loaded FMB, placed in a perfused NMR
tube, were monitored continuously for up to 24 h (Fig 5). A
sensitive indicator of stress is the phosphocreatine (PCr) NMR
signal (around 3 ppm). It gained in intensity immediately following
the loading of the cells on FMB, reaching a maximum after about
3 h. The intensity remained constant thereafter and declined
after 18 h. The corresponding intensity of the ATP β-phosphate
resonances (–8.5 ppm) remained steady throughout the incubation
period (24 h). Similar signal intensities were recorded for perfused
mouse skin (data not shown).
Pig skin wound healing model Full thickness wounds were
made on the paravertebral skin of outbred Yorkshire pigs and filled
with human fibrin with or without other additives or cells, as
described in the Methods and Materials. All wounds were harvested
at day 3 a time when granulation tissue formation normally does
not occur (Welch et al, 1990; Clark et al, 1996; McClain et al,
1996) before the onset of re-epithelialization. In wounds filled
with only fibrin, modest fibroblast proliferation was noted in the
subcutaneous tissue underlying the wounds (Fig 6A). The number
of fibroblasts, possibly accompanied with macrophages that could
not be differentiated from the mass of fibroblasts in the granulation
tissue, increased 2–3-fold when PDGF-BB was added to the
fibrin (Fig 6B). When cultured syngeneic fibroblasts suspended in
exogenous fibrin were added to the wounds, fibroblast-like cells
appeared singly disposed (Fig 6C). In wounds receiving fibroblast
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Figure 4. Micrographs of fibroblasts
on FMB. (a) Confocal microscopy image
of EMT-6 cells on a single FMB. The
composite image of superimposed 50
optical slices reveals µ200 cells loaded on
a single FMB. (b) Fluorescent micrographs
of HF, red PI-stained nuclei, grown on
small FMB. The high cell density
aggregated the beads to form a tissue-like
structure. (c) A combined fluorescent and
light microscopy image of cells loaded on
FMB and embedded in low density fibrin
droplet on a tissue plate. The upper part is
a fluorescence image of the PI red-stained
cell nuclei. The lower half of the image
is combined fluorescent with light
microscopy that shows the borders of the
fibrin gel and the cells migrating from the
FMB (B1) and (B2) with the transluscent
outlines around B2 that indicate the gel
digestion track. (d) Composite super-
imposed slices taken by confocal
microscopy of densely populated FMB as
described in panel (c). The high intensity
PI fluorescence of the nuclei show the
position of cells digesting their way from
the FMB and the surrounding fibrin.
Figure 5. 31P-NMR spectra of endothelial cells on FMB taken over
a period of up to 24 h. The varied PCr signal (~ 13 ppm) indicate the
stress induced consumption of the energy reserves of the cells. By contrast,
the β-ATP signal at ~ –8 ppm reflect the cell viability within the period
of the 21 h follow-up.
and PDGF-BB suspended in the fibrin, small pockets of granulation
tissue were observed at the interface between the fibrin and the
underlying subcutaneous tissue (Fig 6D), as well as increased
numbers of fibroblasts within the fibrin and the subcutaneous tissue.
When only FMB were implanted in the wounds, they were easily
visualized in the base of the wound in the newly formed granulation
tissue (Fig 6E). When PDGF-BB was included in the FMB
suspension, a remarkable increase in the number of fibroblasts was
noted at day 3 in the subcutaneous tissue underlying the wound
(Fig 6F). When FMB loaded with fibroblasts (10 million cells per
g FMB) were applied into the wounds with fibrin, a loosely
organized granulation tissue was observed at the interface between
the FMB and the subcutaneous tissue (Fig 6G). When PDGF-
BB was also included, even greater amounts of more organized
granulation tissue was observed (Fig 6H). Thus, in all scenarios,
FMB appeared to increase fibroblast proliferation compared with
appropriate controls. When FMB were used as carriers for trans-
planted fibroblasts substantial granulation tissue occurred in 3 d
wounds. Compared with FMB control (Fig 6E), the size of the
FMB 3 d after implant was significantly smaller where significant
granulation tissue was formed (Fig 6F–H). The biodegradation of
the implanted FMB seemed to correlate with cell density of the
granulation tissue. It should be noted that neovasculature indicative
of angiogenesis was clearly noted in about 30% of the specimens
in which fibroblasts on FMB had been added to the wounds
without PDGF and in about 60% of the specimens in which
fibroblasts on FMB had been added to the wounds with PDGF.
Thus the tissue organization observed in specimens receiving these
additives is granulation tissue, not simply fibroplasia.
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Figure 6. Pig skin wound healing (day 3). Histology of cutaneous
wounds implanted with 3 mg per ml fibrin and combinations of FMB,
human skin fibroblasts, PDGF-BB, and controls. (A) Wound with no
addition other than human fibrin shows no evidence of granulation tissue.
(B) Wound containing exogenous PDGF-BB shows increased fibroblast
number beneath the wound, but no granulation tissue. (C) Wound to which
fibroblasts suspended in fibrin were added, shows individual fibroblasts in
the fibrin clot, but no granulation tissue. (D) Wound to which fibroblasts
suspended in a fibrin 1 PDGF-BB were added, shows nascent granulation
tissue at the bottom of the wound (arrows) as well as increased numbers of
individual fibroblasts in the fibrin clot. (E) Wound to which FMB suspended
in fibrin were added, shows FMB along the base of the wound. (F) Wound
to which FMB suspended in fibrin 1 PDGF-BB solution were added,
shows FMB along the base of the wound and a great number of fibroblasts
in the underlying subcutaneous tissue (arrows). (G) Wound to which
fibroblast loaded FMB suspended in fibrin were added, shows FMB along
the base of the wound. A large number of fibroblasts were observed
between the FMB and the underlying subcutaneous tissue. (H) Wound to
which fibroblasts loaded FMB suspended in fibrin and PDGF-BB were
added, shows FMB along the base of the wound and robust granulation
tissue between the FMB and in the underlying subcutaneous tissue. Scale
bar: 100 µm.
DISCUSSION
Substrates that can be used to grow cells are essential for a
wide range of applications ranging from advanced tissue culture
techniques to tissue engineering for transplantation. Based on our
experience with fibrin sealant and the haptotactic attraction of cells
to fibrin (Gorodetsky et al, 1998), we developed biodegradable
FMB that were essentially composed of partially heat denatured
fibrin(ogen), cross-linked by the endogenous transglutaminating
activity of factor XIII. For example, fibrinogen denatures above
50°C due to the instability of the D-domains, whereas factor
XIIIa is much more stable and can cross-link proteins at higher
temperatures. Advantage of this was taken by activating
fibrinogen and factor XIII with a low level of thrombin, then
injecting the mixture into moderately heated oil. After processing,
we obtained insoluble, mechanically stable FMB 50–200 µm in
diameter, without utilizing chemical cross-linking reagents (such as
glutaraldehyde) which would inactivate biologically active epitopes
of the proteins. Whereas we originally prepared FMB from purified
components, we could also prepare FMB from cryoprecipitate
which contains other proteins to which cell are attracted such as
fibronectin and von Willebrand factor (Table I). We thereby
obtained insoluble protein microbeads which retained the biologic
effects of fibrin(ogen).
Haptotactic tests indicated that normal and transformed cells
which responded to Sb-Fib, also attached to FMB. These include
fibroblasts, endothelial, smooth muscle, EMT-6 cells and cultured
primary human melanoma cells (Table II, Fig 2). By comparison,
keratinocytes and leukemic cells (J-774.2 and p-388) did not bind
or attach to any of the substrates. It would seem that cells require
appropriate cell receptors to fibrinogen in order to attach onto
the FMB.
The growth of normal cells (kidney epithelial) loaded on FMB
appeared to be optimal with 10% serum in the culture medium
(Fig 2B), although the cells grown on the FMB in lower serum
concentrations still were able to proliferate significantly, but at a
slower rate. Similar growth patterns on FMB were recorded with
other cell types.
Very high cell density on FMB could be achieved. When
appropriately perfused with medium with nutrients and gas mixture,
the cells appeared fully viable and functional. This was reflected
by phosphate signals (i.e., ATP, PCr) as monitored by
31P-NMR.
For example, the phosphate signals generated at the high endothelial
or fibroblast cell density (100 million cells per g FMB) was
equivalent to the signal obtained from normal tissues (data not
shown). Even with full perfusion with medium and aeration, cells
on FMB required some 3 h to recover from the stress of being
transferred into the NMR set-up. Thereafter, the PCr signal was
stronger, only decaying after 18 h (Fig 5). These changes were
possibly due to factors associated with cell stress in the first phase
of their loading into the NMR system and difficulties of maintaining
cells in this system for a prolonged time. Notwithstanding, the
steady ATP 31P signals indicated that the cells were fully viable.
Confocal microscopy provided detailed images of cells attached
to and growing on FMB. The cells on FMB appeared to exhibit
minimal contact inhibition and were capable of achieving extremely
high density (100 million cells per g FMB) for extended periods.
The cells loaded on FMB could subsequently be transferred to
tissue culture plates, either directly or embedded in fibrin gel
(Fig 4). The self-downloading of cells from highly populated FMB
to the transfer site, directly or through the digestion of embedding
fibrin gel, suggests a wide range of application for FMB in cell
transplantation.
Wounds in human skin as well as in the pig model heal through
the formation of granulation tissue which is rarely manifested prior
to the fourth day after wounding. In the pig skin dermal wound
model, by day 3, only wounds which had been implanted with
the combination of FMB 1 fibroblasts demonstrated accelerated
healing and substantial formation of granulation tissue. PDGF-BB,
a potent growth factor (Koyama et al 1994), did not substantially
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accelerate wound healing at this early time point except when
combined with FMB loaded with fibroblasts (Fig 6). The advantage
of fibroblasts transplanted on FMB may, in part, be attributed to
their dense composition, which facilitates settling to the wound
base and thereby allows proper cell orientation within the wound
bed. The observation that FMB appeared to be much smaller 3 d
after their transplantation with cells (Fig 6E–H) corresponds to
our tissue culture experiments wherein the FMB were rapidly
biodegraded (Fig 4c, d). Our positive results with the skin wound
system indicate that implanted FMB with or without cells have
great advantages over current approaches for enhancing wound
healing in skin and possibly for regenerating other tissues.
In conclusion, we describe the characteristics of biodegradable
FMB with a number of projected uses. FMB stimulate cell migration
and permit cell proliferation. They could be used as a matrix to
grow cells, as well as a vehicle to transfer cultured cells from one
milieu to another. The high density of cells on FMB seems to
be associated with the exposure of haptotactic epitopes of the
partially denatured fibrinogen. The porosity of the beads provides
a high surface area for cell attachment and growth. The insolubility
of the FMB and their biodegradable nature make them an ideal
provisional matrix for tissue engineering and cell transplantation.
We are currently studying mechanistic details of cell attraction to
fibrinogen-derived matrices which will expand the uses of FMB
for wound healing and tissue engineering.
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